Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01112579 · ClinicalTrials.gov registry record · Phase 2
Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure
A Phase 2 study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- Phase 2
- Development phase
- 81
- Enrollment target
NCT01112579 is a Phase 2 study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 81 participants.
The verdict
NCT01112579, a Phase 2 study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of spinal cord stimulation (SCS) as a chronic therapy for systolic heart failure.
Interventions
- DEVICE Medtronic PrimeADVANCED Neurostimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2010-04 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01112579
The ClinicalTrials.gov registry entry for NCT01112579 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medtronic PrimeADVANCED Neurostimulator is the first listed.
NCT01112579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01112579 about?
NCT01112579 is a clinical study titled "Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure". The purpose of this study is to determine the feasibility of spinal cord stimulation (SCS) as a chronic therapy for systolic heart failure.
What is the current status of trial NCT01112579?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 81 participants. The study started on 2010-04. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01112579?
The interventions under investigation include: Medtronic PrimeADVANCED Neurostimulator (DEVICE).
Who is sponsoring clinical trial NCT01112579?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.